Clinical Trial

A Study Comparing Tapinarof Cream 1% and Vtama® Cream 1% in the Treatment of Plaque Psoriasis.

Completed Phase 1
View on ClinicalTrials.gov →
Summary
To demonstrate therapeutic equivalence and safety of Tapinarof Cream, 1% (Sun pharma Canada, Inc.) and Vtama® (Tapinarof) Cream, 1% in the treatment of plaque psoriasis.
Trial Details
NCT Number NCT07546214
Lead Sponsor Sun Pharmaceutical Industries, Inc.
Conditions Plaque Psoriasis
Enrollment 575 participants
Start Date 2025-10-13
Primary Completion 2026-03-18 (estimated)
Study Completion 2026-03-18 (estimated)
Updated on ClinicalTrials.gov 2026-04-22